In a recent article published in the JAMA Network, researchers performed an observational study to determine the prevalence of germline genetic testing among all patients aged 20 years or older ...

More evidence points to the benefits of germline genetic testing for patients with various cancers. Such testing can identify mutations that may warrant a change of treatment and allow trying a ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nadine Tung, MD: ...

Please provide your email address to receive an email when new articles are posted on . Approximately 1 in 7 patients with lung cancer had a pathogenic germline ...

Please provide your email address to receive an email when new articles are posted on . Nearly all individuals who self-navigated the entire online platform completed germline testing. The platform ...

During the Miami Breast Cancer Conference and Educated Patient® Breast Cancer Summit, one expert stressed the importance of genetic testing for BRCA mutations. All patients who receive a diagnosis of ...

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...

In a recent study published in the Journal of American Medical Association (JAMA) Oncology, researchers from California investigated the diagnostic outcomes of concurrent sequencing of ...

In their article, Subbiah and Kurzrock 1 contend that the most powerful argument for universal testing is that every patient afflicted with cancer deserves a full diagnosis, which is only possible ...

Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, discussed the importance of germline genetic testing in patients with triple-negative breast cancer and other cancer types.

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR alteration to be of germline origin: 1 The following summarizes recommendations ...

By delivering comprehensive genome-wide coverage of both exonic and intronic regions, Foundation Medicine's WGS Germline test is the company's first assay to provide biopharmaceutical partners with ...